MedTrace Logo

A Randomised Controlled Trial of Family Mediated Exercises (FAME) Following Stroke

NCT00666744 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2008-10-29

No results posted yet for this study

Summary

The aim of the study is to evaluate the functional recovery in two groups of primary stroke patients presenting with moderate/severe disability over a six month period through the implementation of a randomised controlled trial. The first group or the experimental group will receive routine therapy and additional lower limb exercise therapy in the form of family assisted exercises. The second group or the control group will receive routine therapy with no additional formal input from their family members. A secondary aim of the project is to evaluate the impact of the FAME programme on the person with stroke and the individual (s) assisting in the delivery of exercises.

Conditions

  • Weakness
  • Balance

Interventions

OTHER

Family Mediated Exercise Therapy

35 minutes of lower limb exercises to be completed by the person with stroke on a daily basis with the assistance of their family for a period of 8 weeks.

Sponsors & Collaborators

  • Foundation for Medical Research

    collaborator OTHER

  • Friends of the Royal Hospital Donnybrook

    collaborator UNKNOWN

  • University of Dublin, Trinity College

    lead OTHER

Principal Investigators

  • Emma Stokes, PhD · University of Dublin, Trinity College

  • Tara Cusack, PhD · University College Dublin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00666744 on ClinicalTrials.gov